Metformin is a commonly used antidiabetic drug. It has been shown that this drug activates the AMP-activated protein kinase, which inhibits downstream the mammalian target of rapamycin. In addition, several studies indicate that metformin reduces intracellular reactive oxygen species. Our data, using an in vitro rat model, indicate that metformin is able to protect auditory hair cells (HCs) from gentamicin-induced apoptotic cell death. Moreover, metformin has no toxic effect on spiral ganglion neuronal survival or outgrowth in vitro. These results suggest a protective effect of metformin on auditory HC survival in gentamicin-induced HC loss in vitro.

Keywords:
Metformin, Gentamicin, Auditory hair cells
1.
Anisimov VN, Berstein LM, Egormin PA, Piskunovan TS, Popovich IG, Zabezhinski MA, Tyndyk ML, Yurova MV, Kovalenko IG, Poroshina TE, Semenchenko AV: Metformin slows down aging and extends life span of female SHR mice. Cell Cycle 2008;7:2769-2773.
2.
Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R: The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 2004;18:3004-3009.
3.
Battaglia A, Pak K, Brors D, Bodmer D, Frangos J, Ryan AF: Involvement of ras activation in toxic hair cell damage of the mammalian cochlea. Neuroscience 2003;122:1025-1035.
4.
Bailey CJ, Day C: Metformin: its botanical background. Pract Diabetes Int 2004;21:115-117.
5.
Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F: Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 2010;9:1092-1099.
6.
Bodmer D, Brors D, Bodmer M, Ryan AF: Rescue of auditory hair cells from ototoxicity by CEP-11004, an inhibitor of the JNK signaling pathway. Laryngorhinootologie 2002a;81:853-856.
7.
Bodmer D, Brors D, Pak K, Gloddek B, Ryan AF: Rescue of auditory hair cells from aminoglycoside toxicity by Clostridium difficile toxin B, an inhibitor of the small GTPases Rho/Rac/Cdc42. Hear Res 2002b;172:81-86.
8.
Bulterijs S: Metformin as a geroprotector. Rejuvenation Res 2011;14:469-482.
9.
Chang J, Jung HH, Yang JY, Lee SH, Choi J, Im GJ, Chae SW: Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line. J Assoc Res Otolaryngol 2014;15:149-158.
10.
Cheng AG, Cunningham LL, Rubel EW: Mechanisms of hair cell death and protection. Curr Opin Otolaryngol Head Neck Surg 2005;13:343-348.
11.
Chung WH, Pak K, Lin B, Webster N, Ryan AF: A PI3K pathway mediates hair cell survival and opposes gentamicin toxicity in neonatal rat organ of Corti. J Assoc Res Otolaryngol 2006;7:372-382.
12.
Cunningham L, Tan J: Cell death in the inner ear; in Reed JC, Green DR (eds): Apoptosis: Physiology and Pathology. Cambridge, Cambridge University Press, 2011, pp 182-193.
13.
Echteler SM, Nofsinger YC: Development of ganglion cell topography in the postnatal cochlea. J Comp Neurol 2000;425:436-446.
14.
Ernfors P, Van de Water T, Loring J, Jaenisch R: Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 1995;14:1153-1164.
15.
Foller M, Jaumann M, Dettling J: AMP-activated protein kinase in BK-channel regulation and protection against hearing loss following acoustic overstimulation. FASEB J 2012;26:4243-4253.
16.
Gao K, Chi Y, Sun W, Takeda M, Yao J: 5′-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-p38 signaling pathway. Mol Pharmacol 2014;85:460-471.
17.
Guigas B, Detaille D, Chauvin C, Batandier C, De Oliveira F, Fontaine E, Leverve X: Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem J 2004;382:877-884.
18.
Henley CM, Owings MH, Stagner BB, Martin GK, Lonsbury-Martin BL: Postnatal development of 2f1-f2 otoacoustic emissions in pigmented rat. Hear Res 1989;43:141-148.
19.
Hou X, Song J, Li XN, Zhang L, Wang XL, Chen L, Shen YH: Metformin reduces intracellular reactive oxgygen species levels by uregulating expression of the antioxidant thyreoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 2010;396:199-205.
20.
Huang T, Chen AG, Stupak H, Liu W, Kim A, Staecker H, Lefebvre PP, Malgrange B, Kopke R, Moonen G, Van de Water TR: Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci 2000;18:259-270.
21.
Jung HH, Chang J, Yang JY, Choi J, Im GJ, Chae SW: Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell line. Hear Res 2011;282:92-96.
22.
Kusne Y, Goldberg EL, Parker SS, Hapak SM, Maskaykina IY, Chew WM, Limesand KH,Brooks HL, Price TJ, Sanai N, Nikolich-Zugich J, Gosh S: Contrasting effects of chronic, systemic treatmenmt with mTOR inhibitors rapamycin and metformin on adult progenitors in mice. Age 2014;36:199-212.
23.
Lablanche S, Cottet-Rousselle C, Lamarche F, Benhamou PY, Halimi S, Leverve X, Fontaine E: Protection of pancreatic INS-1 b-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporine A or metformin. Cell Death Dis 2011;2:e134.
24.
Lallemend F, Vandenbosch R, Hadjab S, Bodson M, Breuskin I, Moonen G, Lefebvre PP, Malgrange B: New insights into peripherin expression in cochlear neurons. Neuroscience 2007;150:212-222.
25.
Lautermann J, Dehne N, Schacht J, Jahnke K: Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics. Laryngorhinootologie 2004;83:317-323.
26.
Mair W, Morantte I, Rodrigues APC, Manning G, Montminy M: Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature 2011;470:404-408.
27.
Martin-Montalvo A, Mercken EM, Mitchell SJ: Metformin improves healthspan and lifespan in mice. Nat Commun 2013;4:2192.
28.
Matsui JI, Cotanche DA: Sensory hair cell death and regeneration: two halves of the same equation. Curr Opin Otolaryngol Head Neck Surg 2004;12:418-425.
29.
McDowell B: Patterns of cochlear degeneration following gentamicin administration in both old and young guinea pigs. Br J Audiol 1982;16:123-129.
30.
Mihaylova MM, Shaw RJ: The AMPK signaling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011;13:1016-1023.
31.
Mujica-Mota MA, Salehi P, Devic S, Daniel SJ: Safety and otoprotection of metformin in radiation-induced sensorineural hearing loss in the guinea pig. Otolaryngol Head Neck Surg 2014;150:859-865.
32.
Okuda T, Sugahara K, Takemoto T, Shimogori H, Yamashita H: Inhibition of caspases alleviates gentamicin-induced cochlear damage in guinea pigs. Auris Nasus Larynx 2005;32:33-37.
33.
Perla V, Jayanty SS: Biguanide related compounds in traditional antidiabetic function. Food Chem 2013;138:1574-1580.
34.
Pirvola U, Xing-Qun L, Virkkala J, Saarma M, Murakata C, Camoratto AM, Walton KM, Ylikoski J: Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation. J Neurosci 2000;20:43-50.
35.
Priuska EM, Schacht J: Formation of free radicals by gentamicin and iron and evidence for iron/gentamicin complex. Biochem Pharmacol 1995;50:1749-1752.
36.
Rybak LP, Whitworth CA: Ototoxicity: therapeutic opportunities. Drug Discov Today 2005;10:1313-1321.
37.
Rybak LP, Whitworth C, Scott V: Development of endocochlear potential and compound action potential in the rat. Hear Res 1992;59:189-194.
38.
Saitoh M, Nishitoh M, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H: Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998;17:2596-2606.
39.
Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, Cantley LC: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 2004;101:3329-3335.
40.
Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005;310:1642-1646.
41.
Slotta KH, Tschesche R: Über Biguanide. II. Die blutzuckersenkende Wirkung der Biguanide. Chem Ber 1929;62:1398-1405.
42.
Sobkowicz HM, Loftus JM, Slapnick SM: Tissue culture of the organ of Corti. Acta Otolaryngol Suppl 1993;502:3-36.
43.
Werner EA, Bell J: The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction of dicyanodiamide, and methylammonium and dimethylammonium chlorides respectively. J Chem Soc London 1921;121:1790-1795.
44.
Wood JW, Bas E, Gupta C, Selman Y, Eshraghi A, Teleshi FF, Van de Water TR: Otoprotective properties of mannitol against gentamicin induced hair cell loss. Otol Neurol 2014;35:e187-e194.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.